Atyr Pharma, Stock Probability of Future Stock Price Finishing Over 17.74
| ATYR Stock | 3.17 0.12 3.65% |
ATyr |
ATyr Pharma, Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ATyr Pharma, for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for aTyr Pharma, can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| aTyr Pharma, appears to be risky and price may revert if volatility continues | |
| aTyr Pharma, has high likelihood to experience some financial distress in the next 2 years | |
| aTyr Pharma, was previously known as ATyr Pharma and was traded on NASDAQ Exchange under the symbol LIFE. | |
| The company reported the previous year's revenue of 353 K. Net Loss for the year was (50.39 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| ATyr Pharma, generates negative cash flow from operations | |
| aTyr Pharma, has a frail financial position based on the latest SEC disclosures | |
| About 64.0% of the company shares are held by institutions such as insurance companies |
ATyr Pharma, Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of ATyr Stock often depends not only on the future outlook of the current and potential ATyr Pharma,'s investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ATyr Pharma,'s indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 53.6 M | |
| Cash And Short Term Investments | 98.2 M | |
| Shares Float | 73.8 M |
ATyr Pharma, Technical Analysis
ATyr Pharma,'s future price can be derived by breaking down and analyzing its technical indicators over time. ATyr Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of aTyr Pharma,. In general, you should focus on analyzing ATyr Stock price patterns and their correlations with different microeconomic environments and drivers.
ATyr Pharma, Predictive Forecast Models
ATyr Pharma,'s time-series forecasting models is one of many ATyr Pharma,'s stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary ATyr Pharma,'s historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about aTyr Pharma,
Checking the ongoing alerts about ATyr Pharma, for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for aTyr Pharma, help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| aTyr Pharma, appears to be risky and price may revert if volatility continues | |
| aTyr Pharma, has high likelihood to experience some financial distress in the next 2 years | |
| aTyr Pharma, was previously known as ATyr Pharma and was traded on NASDAQ Exchange under the symbol LIFE. | |
| The company reported the previous year's revenue of 353 K. Net Loss for the year was (50.39 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| ATyr Pharma, generates negative cash flow from operations | |
| aTyr Pharma, has a frail financial position based on the latest SEC disclosures | |
| About 64.0% of the company shares are held by institutions such as insurance companies |
Additional Tools for ATyr Stock Analysis
When running ATyr Pharma,'s price analysis, check to measure ATyr Pharma,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATyr Pharma, is operating at the current time. Most of ATyr Pharma,'s value examination focuses on studying past and present price action to predict the probability of ATyr Pharma,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ATyr Pharma,'s price. Additionally, you may evaluate how the addition of ATyr Pharma, to your portfolios can decrease your overall portfolio volatility.